Home

Differential
Counter

Flow
Tutorial

 

  
 
Myeloproliferative
neoplasms		 Neoplasms with eosinophilia
(PDGRA/PDGFRB/FGFR1)		 MDS/MPN MDS AML Acute leukemia
ambiguous lineage
Precursor lymphoid
neoplasms		 Mature B cell
neoplasms		 Mature T and NK
neoplasms		 Hodgkin
lymphoma		 Immunodeficiency associated
lymphoproliferative disorders		 Histiocytic and dendritic
cell neoplasms
 

Acute Myeloid Leukemia, Not Otherwise Specified
  Unusual antigen expression abstracts Prognostic abstracts Cytogenetic abstracts Antigen chart
AML, NOS
AML with recurrent genetic abnormalities
AML with myelodyspasia related changes
Therapy related myeloid neoplasms
Myeloid sarcoma
Myeloid proliferations related to Down's Syndrome
Blastic plasmacytoid dendritic cell neoplasm
Article Antigens evaluated

Cytogenetics and age are major determinants of outcome in intensively treated acute myeloid leukemia patients older than 60 years: results from AMLSG trial AML HD98-B.

t(15;17), inv(16), t(8;21), t(11q23),  -5, -7, del(11q), del(13q), -17, -18, -20, +4, +8, +11, +14, +21, +22, -Y